Xiao-Feng Tang Selected Research

hirulog-like peptide

1/2010	Effect of hirulog-like peptide on balloon catheter injury-induced neointimal formation in femoral arteries of minipigs and relationship with inflammatory mediators.
10/2007	Pharmacokinetics and pharmacology of hirulog-like peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Feng Tang Research Topics

Disease

5	Hypertension (High Blood Pressure) 01/2019 - 10/2012
4	Neoplasms (Cancer) 01/2018 - 03/2013
4	Inflammation (Inflammations) 01/2018 - 10/2012
3	Necrosis 01/2019 - 12/2011
3	Vascular System Injuries 01/2017 - 10/2007
2	Non-alcoholic Fatty Liver Disease 10/2021 - 01/2018
2	Fibrosis (Cirrhosis) 01/2018 - 01/2018
2	Autolysis 07/2010 - 10/2006
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Hypertrophy 01/2019
1	Thyroid Neoplasms (Thyroid Cancer) 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Vascular Calcification 01/2017
1	Vascular Remodeling 04/2016
1	Melanoma (Melanoma, Malignant) 02/2015
1	Nasopharyngeal Carcinoma 02/2015
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 09/2014
1	Dysgerminoma 01/2014
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2014
1	Embryonal Carcinoma 01/2014
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 01/2014
1	Disease Progression 03/2013
1	Esophageal Squamous Cell Carcinoma 03/2013
1	Essential Hypertension 10/2012
1	Hemorrhage 01/2010
1	Disease Resistance 01/2009

Drug/Important Bio-Agent (IBA)

4	Angiotensin IIIBA 01/2019 - 04/2016
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2006
2	Fibronectins (Fibronectin)IBA 01/2019 - 01/2018
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019 - 01/2018
2	CollagenIBA 01/2019 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2018
2	CytokinesIBA 03/2013 - 12/2011
2	Peptide Hydrolases (Proteases)FDA Link 07/2010 - 10/2006
2	hirulog-like peptideIBA 01/2010 - 10/2007
1	Indicators and Reagents (Reagents)IBA 10/2021
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2019
1	SR9243IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Liver X ReceptorsIBA 01/2018
1	Cell Adhesion Molecule-1IBA 01/2018
1	CholesterolIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2018
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2018
1	LipidsIBA 01/2018
1	OsteopontinIBA 01/2017
1	Glycoproteins (Glycoprotein)IBA 01/2017
1	MineralsIBA 01/2017
1	SubtilisinIBA 09/2014
1	Protein Sorting Signals (Signal Peptide)IBA 09/2014
1	peptide AIBA 09/2014
1	ElementsIBA 01/2014
1	C-Reactive ProteinIBA 10/2012
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2012
1	Interferon-gamma (Interferon, gamma)IBA 12/2011
1	Interleukin-10 (Interleukin 10)IBA 12/2011
1	N-(3',4'-dimethoxycinnamonyl)anthranilic acidIBA 12/2011
1	EnzymesIBA 07/2010
1	Reducing AgentsIBA 07/2010
1	Heparin (Liquaemin)FDA LinkGeneric 01/2010
1	P-SelectinIBA 01/2010
1	bivalirudin (Angiomax)FDA Link 01/2010
1	Transcription Factors (Transcription Factor)IBA 01/2009
1	Hormones (Hormone)IBA 01/2009
1	Peptides (Polypeptides)IBA 10/2007
1	Thrombin FDA Link 10/2007
1	DisulfidesIBA 10/2006
1	Dithiothreitol (Cleland's Reagent)IBA 10/2006

Therapy/Procedure

1	Neoadjuvant Therapy 01/2022
1	Chemoradiotherapy 02/2015
1	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2015
1	Immunotherapy 02/2015
1	Therapeutics 01/2014
1	Catheters 01/2010